批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/10/06 |
SUPPL-70(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/12/15 |
SUPPL-69(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/03/05 |
SUPPL-68(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/04/03 |
SUPPL-67(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/07/13 |
SUPPL-66(补充) |
Approval |
Labeling |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
2013/08/16 |
SUPPL-65(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/08/19 |
SUPPL-61(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2004/03/17 |
SUPPL-59(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/04/23 |
SUPPL-58(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/05/07 |
SUPPL-53(补充) |
Approval |
Labeling |
|
|
|
1996/05/07 |
SUPPL-51(补充) |
Approval |
Labeling |
|
|
|
1996/05/07 |
SUPPL-49(补充) |
Approval |
Labeling |
|
|
|
1996/05/07 |
SUPPL-48(补充) |
Approval |
Labeling |
|
|
|
1994/02/16 |
SUPPL-56(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1992/06/23 |
SUPPL-54(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1990/07/30 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1989/04/13 |
SUPPL-50(补充) |
Approval |
Labeling |
|
|
|
1989/02/03 |
SUPPL-47(补充) |
Approval |
Labeling |
|
|
|
1988/02/10 |
SUPPL-41(补充) |
Approval |
Efficacy |
|
|
|
1987/12/28 |
SUPPL-45(补充) |
Approval |
Labeling |
|
|
|
1987/11/03 |
SUPPL-40(补充) |
Approval |
Labeling |
|
|
|
1987/08/21 |
SUPPL-38(补充) |
Approval |
Labeling |
|
|
|
1987/06/18 |
SUPPL-46(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1986/07/22 |
SUPPL-44(补充) |
Approval |
Labeling |
|
|
|
1984/03/30 |
SUPPL-37(补充) |
Approval |
Labeling |
|
|
|
1983/10/18 |
SUPPL-35(补充) |
Approval |
Labeling |
|
|
|
1983/10/18 |
SUPPL-34(补充) |
Approval |
Labeling |
|
|
|
1983/06/02 |
SUPPL-36(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1982/05/05 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1982/02/04 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1981/08/13 |
SUPPL-32(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1981/08/04 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/12/12 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/12/08 |
SUPPL-27(补充) |
Approval |
Labeling |
|
|
|
1980/02/27 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/01/09 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/01/02 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1979/07/26 |
SUPPL-24(补充) |
Approval |
Labeling |
|
|
|
1979/04/19 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1979/03/02 |
SUPPL-23(补充) |
Approval |
Labeling |
|
|
|
1977/08/22 |
SUPPL-19(补充) |
Approval |
Labeling |
|
|
|
1976/10/05 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1975/11/05 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
1974/05/14 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1974/05/14 |
SUPPL-12(补充) |
Approval |
Supplement |
PRIORITY
|
|
|
1963/07/18 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:METRONIDAZOLE 剂型/给药途径:TABLET;ORAL 规格:250MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
012623 |
001 |
NDA |
FLAGYL |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Discontinued |
Yes |
No |
AB |
Approved Prior to Jan 1, 1982
|
PFIZER |
070027 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1984/11/06
|
TEVA PHARMS USA |
070035 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1984/12/20
|
WATSON LABS |
070040 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1985/01/29
|
STRIDES PHARMA |
070772 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1986/07/16
|
INNOGENIX |
079067 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2009/03/13
|
ALEMBIC PHARMS LTD |
203458 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2014/01/22
|
UNICHEM |
203974 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2015/05/29
|
AUROBINDO PHARMA LTD |
205245 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2015/09/23
|
HERITAGE PHARMS INC |
207309 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Discontinued |
No |
No |
AB |
2016/05/16
|
FLAMINGO PHARMS |
208162 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2016/05/25
|
STRIDES PHARMA |
206560 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2016/11/16
|
CADILA |
208681 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/06/20
|
ALEMBIC |
209096 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/09/12
|
LUPIN LTD |
209794 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/12/12
|
CADILA PHARMS LTD |
活性成分:METRONIDAZOLE 剂型/给药途径:TABLET;ORAL 规格:500MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
012623 |
003 |
NDA |
FLAGYL |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Discontinued |
Yes |
No |
AB |
Approved Prior to Jan 1, 1982
|
PFIZER |
070033 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
1984/12/06
|
PLIVA |
070039 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
1985/01/29
|
STRIDES PHARMA |
070044 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
1985/02/08
|
WATSON LABS INC |
070772 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
1986/07/16
|
INNOGENIX |
079067 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2009/03/13
|
ALEMBIC PHARMS LTD |
203458 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2014/01/22
|
UNICHEM |
203974 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
Yes |
AB |
2015/05/29
|
AUROBINDO PHARMA LTD |
205245 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2015/09/23
|
HERITAGE PHARMS INC |
207309 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Discontinued |
No |
No |
AB |
2016/05/16
|
FLAMINGO PHARMS |
208162 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2016/05/25
|
STRIDES PHARMA |
206560 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2016/11/16
|
CADILA |
208681 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2017/06/20
|
ALEMBIC |
209096 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2017/09/12
|
LUPIN LTD |
209794 |
002 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2017/12/12
|
CADILA PHARMS LTD |